Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pilot study of thalidomide in myelodysplastic syndrome yields encouraging results

Aug. 21, 2001

Phase I study successful for Prescient NeuroPharma's anhydrovinblastine

Aug. 20, 2001

Geron and Kyowa Hakko select telomerase inhibitor for development

Aug. 20, 2001

Encouraging phase I results reported for Supratek's lead oncology product

Aug. 20, 2001

Onyx regains development rights for nonintravenous administration of ONYX-015

Aug. 20, 2001

Zeltia and Ortho Biotech announce licensing agreement for ET-743

Aug. 14, 2001

Strategy for systemic administration of Reolysin explored

Aug. 13, 2001

Merck & Co. reports novel farnesyltransferase inhibitor with excellent cell potency

Aug. 13, 2001

First nonpeptide somatotropin sst3 antagonists reported

Aug. 13, 2001

Urokinase inhibitors with antiangiogenic activity reported by Abbott

Aug. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.